GIF Investment Director Lily Steele (left) and Blackfrog CEO Mayur Shetty with an Emvólio backpack.
Cold chain logistics are critical to modern healthcare. From vaccine distribution and diagnostic sample transport to biopharmaceuticals and research reagents, medical-grade refrigeration directly impacts safety, effectiveness, and compliance.
Blackfrog’s flagship product, Emvólio, is a compact, portable, and digitally enabled refrigeration system, engineered for medical-grade performance and compliance. It uses thermoelectric cooling, live temperature tracking, and data analytics to ensure traceability, precision, and stability across the cold chain.
Deployed across 800+ health centers in India, as well as in Nigeria and Kenya, Emvólio has demonstrated reliability in last-mile settings. Now, Blackfrog is translating that same performance into high-volume commercial markets—especially pharma logistics, diagnostics, and research environments that demand uncompromising temperature control.
With this funding, Blackfrog is set to:
“We’re building a pipeline of innovations that will broaden our cold chain portfolio beyond Emvólio. These upcoming products are designed specifically for diagnostics and pharma logistics,” said Mayur Shetty, CEO at Blackfrog.
“By next year, we’ll be manufacturing and deploying them at scale. This is a decisive step toward our long-term vision: becoming India’s market leader in medical refrigeration by 2030.”
“Today, there are deep-rooted inefficiencies in medical cold chains. Current methods for transporting vaccines, insulin, biologics, and even corneal tissue suffer from inconsistent temperature control, compromising effectiveness and safety,” said Vishvesh Krishna, Investment Manager at Rainmatter Capital.
“Blackfrog’s advanced thermoelectric cooling technology addresses these gaps, ensuring precise, stable, and medical-grade cooling. Our support for Blackfrog is a bet on the future of healthcare logistics.”
“This investment not only reinforces our commitment to improving quality of public healthcare delivery systems but also is an amplification of our continued support to nurture ‘innovations for public good,’” said Mr. Harinarayan Sharma, Vice President at MEMG.
“The investment by GIF is a great endorsement of the power of innovation spearheaded by our Alumni and for an idea incubated at the University Technology Incubator platform,” said Dr. Santhosha Rao, CEO, Manipal Universal Technology Business Incubator (MUTBI).
“Our aim is to support Blackfrog’s growth by building its commercial sales track record and manufacturing, showing the company can convert pilot projects into larger order volumes, and also develop new product lines to serve new markets,” said Lily Steele, Investment Director at the Global Innovation Fund (GIF).
“Blackfrog is exactly the kind of business we seek to support through Thrive—our new climate-health fund focused on innovations that enhance public health in a warming world.”
“We are grateful to be part of the Thrive initiative — a collaborative effort between PATH and GIF,” said Donson Dsouza, COO of Blackfrog. “We’re especially thankful to PATH for their technical support as we work together to strengthen climate-resilient health systems.”
Blackfrog’s solutions go beyond cooling—they bring data-driven control, regulatory compliance, and supply chain transparency to healthcare delivery. This funding round will support the company’s expansion into commercial segments that demand high reliability, such as vaccine logistics, diagnostics, and research labs.
Blackfrog is actively seeking:
Contact- info@blackfrog.in